Squarepoint’s Enanta Pharmaceuticals ENTA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-11,558
| Closed | -$66.5K | – | 2887 |
|
|
2024
Q4 | $66.5K | Buy |
+11,558
| New | +$66.5K | ﹤0.01% | 2609 |
|
|
2024
Q1 | – | Sell |
-106,403
| Closed | -$1M | – | 2560 |
|
|
2023
Q4 | $1M | Buy |
106,403
+78,922
| +287% | +$743K | ﹤0.01% | 1346 |
|
|
2023
Q3 | $307K | Buy |
+27,481
| New | +$307K | ﹤0.01% | 1913 |
|
|
2023
Q2 | – | Sell |
-9,533
| Closed | -$386K | – | 2498 |
|
|
2023
Q1 | $386K | Sell |
9,533
-4,285
| -31% | -$173K | ﹤0.01% | 1572 |
|
|
2022
Q4 | $643K | Buy |
13,818
+8,605
| +165% | +$400K | ﹤0.01% | 1335 |
|
|
2022
Q3 | $270K | Buy |
+5,213
| New | +$270K | ﹤0.01% | 1675 |
|
|
2021
Q3 | – | Sell |
-4,924
| Closed | -$217K | – | 2361 |
|
|
2021
Q2 | $217K | Buy |
+4,924
| New | +$217K | ﹤0.01% | 2175 |
|
|
2020
Q4 | – | Sell |
-5,271
| Closed | -$241K | – | 2613 |
|
|
2020
Q3 | $241K | Sell |
5,271
-1,266
| -19% | -$57.9K | ﹤0.01% | 1830 |
|
|
2020
Q2 | $328K | Sell |
6,537
-15,074
| -70% | -$756K | 0.01% | 1513 |
|
|
2020
Q1 | $1.11M | Buy |
21,611
+9,674
| +81% | +$497K | 0.03% | 677 |
|
|
2019
Q4 | $737K | Sell |
11,937
-22,561
| -65% | -$1.39M | ﹤0.01% | 1489 |
|
|
2019
Q3 | $2.07M | Buy |
34,498
+27,303
| +379% | +$1.64M | 0.02% | 810 |
|
|
2019
Q2 | $607K | Sell |
7,195
-3,209
| -31% | -$271K | 0.01% | 1524 |
|
|
2019
Q1 | $994K | Sell |
10,404
-11,887
| -53% | -$1.14M | 0.01% | 1106 |
|
|
2018
Q4 | $1.58M | Buy |
22,291
+11,987
| +116% | +$849K | 0.02% | 742 |
|
|
2018
Q3 | $881K | Sell |
10,304
-7,686
| -43% | -$657K | 0.01% | 1047 |
|
|
2018
Q2 | $2.09M | Sell |
17,990
-6,187
| -26% | -$717K | 0.03% | 609 |
|
|
2018
Q1 | $1.96M | Sell |
24,177
-2,289
| -9% | -$185K | 0.03% | 582 |
|
|
2017
Q4 | $1.55M | Buy |
+26,466
| New | +$1.55M | 0.03% | 642 |
|
|
2017
Q1 | – | Sell |
-8,098
| Closed | -$271K | – | 1609 |
|
|
2016
Q4 | $271K | Sell |
8,098
-787
| -9% | -$26.3K | 0.01% | 1215 |
|
|
2016
Q3 | $236K | Buy |
+8,885
| New | +$236K | 0.02% | 837 |
|
|
2016
Q2 | – | Sell |
-8,000
| Closed | -$235K | – | 1167 |
|
|
2016
Q1 | $235K | Sell |
8,000
-4,532
| -36% | -$133K | 0.02% | 935 |
|
|
2015
Q4 | $414K | Buy |
+12,532
| New | +$414K | 0.05% | 634 |
|